While SAB-185 previously met the initial pre-specified safety and efficacy criteria to continue to the next phase of the Phase 3 ACTIV-2 trial, the independent Data and Safety Monitoring Board (DSMB) recommended that the study be stopped for ...
Additionally, Noursi explained that pharmacy professionals play critical roles in laboratory research and clinical trials, coordination of studies, identifying toxic responses, monitoring for AEs, and serving on data safety and monitoring committees and as principal investigators. “Many pha...
However, current data shows that most patients using BurstDR™ stimulation therapy do not experience paresthesia. For patients who do not feel paresthesia, sudden stimulation changes are less likely to occur and distract them while operating motorized vehicles, machinery, or equipment. Explosive and...
The NIH prospective study on all aspects of ZES has been in effect since 1974, and part of the study involves the long-term medical management of the acid hypersecretion of all patients [37,74,86,125,126,127]. In the current study, we analyzed data from this prospective database ...